Understanding this interaction not only sheds light on the molecular underpinnings of colorectal cancer but also opens the door for developing targeted therapies that could inhibit the JAK/STAT3 pathway, KIF20A expression, or both, offering hope for more effective treatments for this challenging disease. The gene discussed is STAT3; the disease is colorectal cancer.